scholarly journals Access to Mechanical Thrombectomy for Ischemic Stroke in the United States

Stroke ◽  
2021 ◽  
Author(s):  
Hooman Kamel ◽  
Neal S. Parikh ◽  
Abhinaba Chatterjee ◽  
Luke K. Kim ◽  
Jeffrey L. Saver ◽  
...  

Background and Purpose: Mechanical thrombectomy helps prevent disability in patients with acute ischemic stroke involving occlusion of a large cerebral vessel. Thrombectomy requires procedural expertise and not all hospitals have the staff to perform this intervention. Few population-wide data exist regarding access to mechanical thrombectomy. Methods: We examined access to thrombectomy for ischemic stroke using discharge data from calendar years 2016 to 2018 from all nonfederal emergency departments and acute care hospitals across 11 US states encompassing 80 million residents. Facilities were classified as hubs if they performed mechanical thrombectomy, gateways if they transferred patients who ultimately underwent mechanical thrombectomy, and gaps otherwise. We used standard descriptive statistics and unadjusted logistic regression models in our primary analyses. Results: Among 205 681 patients with ischemic stroke, 100 139 (48.7% [95% CI, 48.5%–48.9%]) initially received care at a thrombectomy hub, 72 534 (35.3% [95% CI, 35.1%–35.5%]) at a thrombectomy gateway, and 33 008 (16.0% [95% CI, 15.9%–16.2%]) at a thrombectomy gap. Patients who initially received care at thrombectomy gateways were substantially less likely to ultimately undergo thrombectomy than patients who initially received care at thrombectomy hubs (odds ratio, 0.27 [95% CI, 0.25–0.28]). Rural patients had particularly limited access: 27.7% (95% CI, 26.9%–28.6%) of such patients initially received care at hubs versus 69.5% (95% CI, 69.1%–69.9%) of urban patients. For 93.8% (95% CI, 93.6%–94.0%) of patients with stroke at gateways, their initial facility was capable of delivering intravenous thrombolysis, compared with 76.3% (95% CI, 75.8%–76.7%) of patients at gaps. Our findings were unchanged in models adjusted for demographics and comorbidities and persisted across multiple sensitivity analyses, including analyses adjusting for estimated stroke severity. Conclusions: We found that a substantial proportion of patients with ischemic stroke across the United States lacked access to thrombectomy even after accounting for interhospital transfers. US systems of stroke care require further development to optimize thrombectomy access.

Stroke ◽  
2016 ◽  
Vol 47 (suppl_1) ◽  
Author(s):  
Limin Wang ◽  
Merry Holliday-Hanson ◽  
Joseph Parker

Objectives: A report on ischemic stroke care at California hospitals was based on risk-adjusted 30-day mortality and accounted for many important risk factors (patient demography, clinical characteristics, and stroke severity). Other studies have indicated that geographic location, hospital characteristics and insurance type may also be drivers of differences in quality of care. The effect that these and other factors may have on hospital performance ratings for ischemic stroke is not well understood. Methods: Data used were from the California patient discharge data 2011-2013, collected by the Office of Statewide Health Planning and Development (OSHPD). Hospitals were chosen according to their performance in two recent hospital “report cards” on stroke produced by OSHPD. We compared 15 hospitals rated as “Better” with 14 “Worse” hospitals (10615 patients) on patient demographics, geographic location, insurance type, hospital characteristics, tissue-type plasminogen activator (tPA) use and expected 30-day mortality rate. Results: Patients admitted to “Worse” hospitals were more likely to be younger, white or Hispanic, and reside in lower income zip codes than “Better” hospitals ( P <0.001). “Worse” hospitals served a significantly higher percentage of patients with Medi-Cal insurance than “Better” hospitals (14.4% vs 9.6%, P <0.001). There were no significant differences in hospital geography or teaching status, bed size or Get With the Guidelines-Stroke Hospitals status between “Worse” and “Better” hospitals. Patients admitted to “Worse” hospitals had similar lengths of stay as those at “Better” hospitals and the transfer rate was also similar. “Worse” hospitals coded significantly fewer secondary diagnoses compared to “Better” hospitals (40.5% vs 53.0%, P <0.005). The tPA usage rate was significantly higher in the “worse” group than the “Better” group (11.5% vs 9.2%, P <0.005). “Worse” hospitals had significantly lower expected 30-day mortality rates compared to “Better” hospitals (8.8% vs 11.6%, P <0.005). Conclusion: Hospital performance ratings on ischemic stroke outcome were significantly associated with patient geographic location, socioeconomic status, and insurance type, but were not related to hospital characteristics.


1997 ◽  
Vol 150 ◽  
pp. S14
Author(s):  
D. Ryglewicz ◽  
D. Hier ◽  
M. Wiszniewska ◽  
M. Barańska-Gieruszczak ◽  
S. Cichy ◽  
...  

2018 ◽  
pp. 23-36
Author(s):  
Cynthia L. Kenmuir ◽  
Tudor G. Jovin

Ischemic stroke accounts for 87% of all strokes and remains a leading cause of death and disability in the United States. Early evaluation and management is critical for good outcomes. The neurocritical care team may be the first responders to in-hospital strokes and will become involved in the management of more complicated issues involved in stroke care. As such, this chapter is split into two sections: the first focuses on acute treatment of acute ischemic strokes (AIS) and the second discusses intensive care unit management of AIS.


Stroke ◽  
2021 ◽  
Author(s):  
Pratyaksh K. Srivastava ◽  
Shuaiqi Zhang ◽  
Ying Xian ◽  
Hanzhang Xu ◽  
Christine Rutan ◽  
...  

Background and Purpose: The coronavirus disease 2019 (COVID-19) pandemic has created challenges in the delivery of acute stroke care. In this study, we analyze the characteristics, evaluation, treatment, and in-hospital outcomes of patients presenting with acute ischemic stroke (AIS) pre-COVID-19 and during COVID-19. Methods: Get With The Guidelines-Stroke is a national registry of adults with stroke in the United States. Using this registry, we identified patients with a diagnosis of AIS before (n=39 113; November 1, 2019–February 3, 2020) and after (n=41 971; February 4, 2020–June 29, 2020) the first reported case of COVID-19 in the registry. Characteristics, treatment patterns, quality metrics, and in-hospital outcomes were compared between the 2 groups. Results: Stroke presentations decreased by an average of 15.3% per week in the during COVID-19 time period when compared with similar months in 2019. Compared with patients with AIS in the pre-COVID-19 era, patients in the COVID-19 time period had similar rates of intravenous alteplase and endovascular therapy, and similar door to computed tomography, door to needle, and door to endovascular therapy times. In adjusted models, inpatient mortality was similar between those presenting with AIS pre-COVID-19 and during COVID-19 (4.8% versus 5.2%; odds ratio, 1.05 [95% CI, 0.97–1.13]). Conclusions: Among hospitals participating in Get With The Guidelines-Stroke, patients presenting with AIS during COVID-19 received, with few exceptions, similar quality care and experienced similar risk-adjusted outcomes when compared with patients with AIS presenting pre-COVID-19. These findings demonstrate that stroke care in the United States remains robust during the COVID-19 pandemic.


2018 ◽  
Vol 75 (4) ◽  
pp. 515 ◽  
Author(s):  
Hooman Kamel ◽  
Caroline D. Chung ◽  
Gbambele J. Kone ◽  
Ajay Gupta ◽  
Nicholas A. Morris ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document